...
首页> 外文期刊>Journal of Colloid and Interface Science >Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent
【24h】

Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent

机译:界面层润湿性和厚度对药物洗脱支架涂层形态和西罗莫司释放的影响

获取原文
获取原文并翻译 | 示例

摘要

Drug-eluting stents (DESs) have been used to treat coronary artery diseases by placing in the arteries. However, current DESs still suffer from polymer coating defects such as delamination and peeling-off that follows stent deployment. Such coating defects could increase the roughness of DES and might act as a source of late or very late thrombosis and might increase the incident of restenosis. In this regard, we modified the cobalt-chromium (Co-Cr) alloy surface with hydrophilic poly(2-hydroxyethyl methacrylate) (PHEMA) or hydrophobic poly(2-hydroxyethyl methacrylate)-grafted-poly(caprolactone) (PHEMA-g-PCL) brushes. The resulting surfaces were biocompatible and biodegradable, which could act as anchoring layer for the drug-in-polymer matrix coating. The two modifications were characterized by ATR-FTIR, XPS, water contact angle measurements, SEM and AFM. On the control and modified Co-Cr samples, a sirolimus (SRL)-containing poly(D,L-lactide) (PDLLA) were ultrasonically spray-coated, and the drug release was examined for 8 weeks under physiological conditions. The results demonstrated that PHEMA as a primer coating improved the coating stability and degradation morphology, and drug release profile for short-term as compared to control Co-Cr, but fails after 7 weeks in physiological buffer. On the other hand, the hydrophobic PHEMA-g-PCL brushes not only enhanced the stability and degradation morphology of the PDLLA coating layer, but also sustained SRL release for long-term. At 8-week of release test, the surface morphologies and release profiles of coated PDLLA layers verified the beneficial effect of hydrophobic PCL brushes as well as their thickness on coating stability. Our study concludes that 200 nm thickness of PHEMA-g-PCL as interfacial layer affects the stability and degradation morphology of the biodegradable coating intensively to be applied for various biodegradable-based DESs. (C) 2015 Elsevier Inc. All rights reserved.
机译:药物洗脱支架(DES)已通过放置在动脉中来治疗冠状动脉疾病。然而,当前的DES仍然遭受聚合物涂层缺陷,例如在支架展开之后的分层和剥离。这样的涂层缺陷可能会增加DES的粗糙度,并可能导致晚期或非常晚期的血栓形成,并可能增加再狭窄的发生率。在这方面,我们用亲水性的聚甲基丙烯酸2-羟乙酯(PHEMA)或疏水的聚甲基丙烯酸2-羟乙酯接枝的聚己内酯(PHEMA-g-)改性了钴铬合金表面。 PCL)刷子。所得表面是生物相容性和可生物降解的,可充当聚合物中药物基质涂层的锚固层。通过ATR-FTIR,XPS,水接触角测量,SEM和AFM来表征这两个修改。在对照和修饰的Co-Cr样品上,超声喷涂含西罗莫司(SRL)的聚(D,L-丙交酯)(PDLLA),并在生理条件下检查药物释放8周。结果表明,与对照Co-Cr相比,PHEMA作为底漆涂层改善了涂层的稳定性和降解形态,并改善了短期药物释放曲线,但在生理缓冲液中7周后失效。另一方面,疏水性PHEMA-g-PCL刷不仅可以增强PDLLA涂层的稳定性和降解形态,而且可以长期持续释放SRL。在8周的脱模测试中,涂覆的PDLLA层的表面形态和释放曲线证实了疏水性PCL刷的有益效果以及其厚度对涂层稳定性的影响。我们的研究得出结论,作为界面层的PHEMA-g-PCL厚度为200 nm,会强烈影响可生物降解涂层的稳定性和降解形态,从而将其广泛应用于各种可生物降解的DES。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号